Expert committees

Missions and Roles of Expert Committees

These committees provide expertise in accordance with the charter on health expertise to produce an opinion, a recommendation, or an interpretation (data analysis) that will influence public policy (e.g., plans, regulatory measures, prevention programs, etc.) or public health interventions (e.g., best practice measures, management measures, etc.).

Members are selected following a public call for applications, based in particular on the information provided in the application materials, the candidates’ alignment with the required expertise, an analysis of conflicts of interest, and the necessary multidisciplinary and diverse composition of the group to address the full scope of the issue at hand.

The final opinion issued by Santé publique France incorporates the expert committee’s opinion/report, including its full rationale and scientific conclusions, on the basis of which the agency issues recommendations that help define options for management measures or actions to be implemented by public authorities.

The Scientific Council first reviews the appropriateness of establishing an expert committee within Santé publique France. Expert committees are attached to the agency’s directorates, which provide scientific coordination and administrative secretariat support. Work is conducted according to a detailed expert review process and in accordance with the expert committees’ internal rules of procedure.

Each member of these committees must complete a public declaration of interests and adhere to the ethical principles of Santé publique France. As part of the system for managing and preventing conflicts of interest established by Santé publique France, any potential conflicts of interest among committee members were verified before and during the committees’ work, and the necessary management measures were implemented. Declarations of interest are published on the DPI SANTE consultation website.

Opinions

The opinions and recommendations produced as part of the Agency’s expert work are available by clicking here.

Active committees

Expert Committee on Health, Environment, and Labor

Appointed on December 8, 2022, for a three-year term by decision of the General Directorate of Santé publique France, the Health-Environment-Work (SET) Expert Committee’s primary mission is to issue opinions and recommendations aimed at protecting the health of populations exposed to environmental or occupational hazards.

It may be consulted by Santé publique France to:

  • issue an opinion on actions to be taken following health or environmental events and/or on the appropriateness of initiating SET studies or surveillance systems, or even suspending them;

  • develop recommendations following the investigation of signals or based on the results of SET studies or surveillance systems. These recommendations may be intended for the Agency, as well as for the overseeing authority or bodies that refer matters to Santé publique France, or even for research teams.

It may be mobilized in the context of a specific case or based on a dataset. This may involve:

  • a set of results on a specific topic for which the Agency may wish to issue recommendations to the general public or government authorities;

  • a pool of requests or signals raising questions about the need to conduct larger-scale studies given the increasing number of such signals.

It may include methodological work within its scope of investigation or even cross-cutting methodological reflections (related to methodological frameworks supported by the agency or to cross-cutting considerations).

ALLES Benjamin, BEAUNE Xavier, BOELS David, DEMATTEI Christophe, DESQUEYROUX Hélène, DEWITTE Jean-Dominique, DUCA Radu, EDEY-GAMASSOU Claire, GISLARD Antoine, GLORENNEC Philippe, LERAY Fabrice, LEROYER Christophe, MARANO Francelyne (Vice President), MERCKEL Olivier, MUNOZ Jorge, PREVOT-CARPENTIER Muriel, SIMOS Jean (President).

Minutes of Decisions

Agency Opinion

National Expert Committee on Maternal Mortality

The Confidential National Survey on Maternal Mortality (ENCMM) was established in 1995 by Inserm. It is a system for monitoring maternal mortality in France, with a twofold objective: first, an epidemiological goal of comprehensively recording cases of maternal death; and second, an analysis of the care provided and the preventable circumstances that led to the death. This study relies on a specialized medical review of each case conducted by experts from the National Committee of Experts on Maternal Mortality (CNEMM).

The CNEMM was established by a decree of the Ministry of Health on May 2, 1995, with the mission to examine maternal deaths documented by the ENCMM, identify the factors contributing to these deaths, and propose preventive measures for the management of pregnancy and childbirth. Until 2006, when this decree was repealed, the CNEMM’s activities were under the direct supervision of the General Directorate of Health (DGS). Management was then entrusted to the French Institute for Public Health Surveillance (InVS) until 2011, and subsequently handled by the French National Authority for Health (HAS) until 2014. In 2014, a decision by the DGS reassigned the InVS the task of overseeing the long-term system for in-depth study of maternal mortality in France.

Santé publique France took over the secretariat of the CNEMM upon its creation in 2016; this is an expert committee, in accordance with its classification of committees. Every three years, this committee drafts the ENCMM report, published on the Santé publique France website, on the basis of which Santé publique France does not issue an opinion.

The committee is responsible for:

  • the confidential analysis, characterization, and classification of all maternal deaths in France, based on data from the confidential national survey on maternal deaths (ENCMM);

  • identifying the factors contributing to these deaths; proposing preventive measures regarding maternal mortality;

  • drafting a triennial report on the epidemiological profile and causes of maternal mortality, and trends in these areas.

BARROIS Mathilde, BONNIN Martine, BOZEC LE MOAL Laurence, BRUYERE Marie, CHIESA Coralie, DENEUX-THARAUX Catherine, DREYFUS Michel, FISCHER Catherine, GROSSETTI Elisabeth, HEBBACHE Zina, IRAOLA Elisabeth, JONARD Marie, LEJEUNE Véronique, RIGOUZZO Agnès, ROSSIGNOL Mathias, SAUSSARD-EBOUE Florence, Odile Souchaud-Debouverie, Marie-Noëlle Vacheron, Eric Verspyk, Sylvie Viaux-Savelon.

For 2024: February 6, April 2, October 8, November 5, December 19

For 2025: February 12, March 14, April 1, May 13, June 3, July 8

Expert Committee on Congenital Anomalies

As part of its mandate to “continuously monitor and observe the health status of the population,” Santé publique France monitors congenital anomalies, which are among the major determinants of perinatal and neonatal health. Congenital anomalies are, in fact, one of the leading causes of infant mortality, morbidity, and disability in industrialized countries for which data are available.

The epidemiological surveillance system for congenital anomalies relies on seven surveillance registries that collect data on cases of children with congenital anomalies, regardless of gestational age at birth. Santé publique France coordinates the national surveillance of congenital anomalies.

With a view to improving perinatal health and recommending measures to protect the health of women, newborns, and their families, a multidisciplinary expert committee was established in 2024 to:

  • formulate an opinion and recommendations on exceptional prioritization criteria justifying the investigation of a suspected spatio-temporal cluster;

  • develop recommendations for a work plan for the surveillance of congenital anomalies, in particular:

    • establish a standardized methodology for detecting changes in prevalence and issue recommendations on the interpretation of these prevalence trend results;

    • formulate a prioritization of groups or subgroups of congenital anomalies to be monitored at the national level within the SNDS.

ALESSANDRI Jean-Luc, ATTALLAH Anthony, BARJAT-RAIA Tiphanie, BEEKER Nathanaël, BENACHI Alexandra, BENETEAU Claire, BOGHOSSIAN Nansi, BROUGHAN Jennifer, DHOMBRES Ferdinand, DUBUCS-GAUTIER Charlotte, EDERY Patrick, GARNE Ester, JOHNSON Kathryn, KERMORVANT-DUCHEMIN Elsa, LESIEUR Emmanuelle, MARIN Benoit, NEMBHARD Wendy, PATRIER-SALLEBERT Sophie, PHILIPPAT Claire, ROMITTI Paul, SAINT FRISON Marie-Hélène

For 2024: April 8, October 7

For 2025: January 13, March 20, June 16, October 9 and 10

For the year 2026: March 26

Committees whose terms have expired

Expert Committee on Local Public Health Resources in Exceptional Public Health Situations

Established in 2017, the committee was reappointed in 2021 for a three-year term, by decision of the General Directorate of Santé publique France. The primary mission of the Expert Committee on Health Resources in Exceptional Health Situations is to issue opinions and formulate technical and operational recommendations on response procedures and the resources required to continue preparing the health system for exceptional health situations. The Committee’s term of office ended on July 31, 2024.

In particular, it may:

  • propose operational guidelines for the response of healthcare professionals in the event of exceptional health situations, particularly regarding the care of victims;

  • assess the resources and response methods of healthcare professionals established to address exceptional health situations;

  • make proposals regarding the material resources that could be made available to healthcare professionals to address exceptional health situations;

  • propose guidelines for the use of such equipment and assess the training needs of healthcare professionals;

  • contribute to the collection and dissemination of best practices and information derived from French and international research and development in the field;

  • propose response measures for exceptional health situations (whether of civil or military origin, natural, accidental, or malicious).

The scope of the expert committee covers, in particular, the following types of equipment:

  • mobile medical stations (MMS):

    • Level 1 MHCs for treating 25 victims,

    • Level 2 PSMs for treating 500 victims,

    • pediatric MHCs for treating 25 pediatric victims,

    • Overseas PSMs adapted to the specific needs of overseas territories for treating 400 victims;

  • personal protective equipment;

  • detection, protection, and decontamination equipment;

  • telecommunications equipment;

  • mobile transport and backup ventilators for healthcare facilities;

  • and any item likely to constitute an effective countermeasure in exceptional health situations, enabling an early response to rapidly strengthen pre-hospital response capabilities to address a nuclear, radiological, biological, chemical, or explosive incident.

BALLAND Olivier, BERNIGAUD Emmanuel, BERTRAND Catherine, BOUTOT Françoise, BRILLOIT CHEVALLIER Christine, CHAPPUY Hélène, COIGNARD-BIEHLER Hélène, DECROUY Nicolas, DELAVAL-CHEMINOT Agnès, DESANLIS Cyril, DO MONTE Pedro, FAVIER Christian, GILLET Stéphane, GUIMIER Jean-Baptiste, JOSSE Denis, JULIEN Henri, KIRCHE Stéphane, LE BAGOUSSE-BERNARD Aurélie, LOUBIGNAC François, MEGARBANE Bruno, PETITJEAN Isabelle, PIERANTONI Emmanuel, PONS François, RAMDANI Alaa, RAYNAUD-LAMBINET Anne, RIGAL Sylvain, SOUPIZET François, TELION Caroline,
VAN HEEMS François, VIVIEN Benoit (chair), WALCKENAER Maylis.